DE3784308T2 - Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis. - Google Patents

Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.

Info

Publication number
DE3784308T2
DE3784308T2 DE8787115790T DE3784308T DE3784308T2 DE 3784308 T2 DE3784308 T2 DE 3784308T2 DE 8787115790 T DE8787115790 T DE 8787115790T DE 3784308 T DE3784308 T DE 3784308T DE 3784308 T2 DE3784308 T2 DE 3784308T2
Authority
DE
Germany
Prior art keywords
somatostatin
rheumatoid arthritis
treatment
production
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787115790T
Other languages
English (en)
Other versions
DE3784308D1 (de
Inventor
Marco Matucci Cerinic
Simone Marabini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SpA
Original Assignee
Industria Farmaceutica Serono SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industria Farmaceutica Serono SpA filed Critical Industria Farmaceutica Serono SpA
Application granted granted Critical
Publication of DE3784308D1 publication Critical patent/DE3784308D1/de
Publication of DE3784308T2 publication Critical patent/DE3784308T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8787115790T 1986-11-04 1987-10-27 Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis. Expired - Lifetime DE3784308T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8648617A IT1208760B (it) 1986-11-04 1986-11-04 Trattamento delle malattie infiammatorie articolari

Publications (2)

Publication Number Publication Date
DE3784308D1 DE3784308D1 (de) 1993-04-01
DE3784308T2 true DE3784308T2 (de) 1993-07-08

Family

ID=11267657

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787115790T Expired - Lifetime DE3784308T2 (de) 1986-11-04 1987-10-27 Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.

Country Status (11)

Country Link
US (1) US4966889A (de)
EP (1) EP0266665B1 (de)
JP (1) JPH0725693B2 (de)
AT (1) ATE85893T1 (de)
DE (1) DE3784308T2 (de)
ES (1) ES2053499T3 (de)
GR (1) GR3007141T3 (de)
HK (1) HK139796A (de)
IL (1) IL84327A (de)
IT (1) IT1208760B (de)
MX (1) MX9203339A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
EP2389930A1 (de) * 2006-03-31 2011-11-30 Erasmus University Medical Center Rotterdam Neue zusammensetzung zur kontrolle des tumorwachstums
AU2017277747A1 (en) * 2016-06-10 2019-01-17 Regulaxis Peptides for the treatment of osteoarthritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748153A (en) * 1985-04-29 1988-05-31 Merck & Co., Inc. Compounds having somatostatin-like activity useful as local anti-inflammatory agents
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents

Also Published As

Publication number Publication date
HK139796A (en) 1996-08-02
MX9203339A (es) 1992-08-31
IL84327A (en) 1991-09-16
EP0266665B1 (de) 1993-02-24
US4966889A (en) 1990-10-30
ATE85893T1 (de) 1993-03-15
JPH0725693B2 (ja) 1995-03-22
IL84327A0 (en) 1988-04-29
IT1208760B (it) 1989-07-10
EP0266665A2 (de) 1988-05-11
IT8648617A0 (it) 1986-11-04
JPS63179832A (ja) 1988-07-23
EP0266665A3 (en) 1989-10-25
GR3007141T3 (de) 1993-07-30
DE3784308D1 (de) 1993-04-01
ES2053499T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
FI905956A0 (fi) Foerfarande foer producering av ett biologiskt aktivt protein.
DE69333607D1 (de) Vorrichtung zur Herstellung von vorgefüllten, sterilen Abgabevorrichtungen
DE3770956D1 (de) Flavonglycosid, verfahren zur herstellung und pharmazeutische zusammensetzung, welche dieses produkt enthaelt.
DE59008005D1 (de) Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden.
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
DE3784308T2 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
DE58901037D1 (de) Vorrichtung zur herstellung von klareisstuecken.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ATE166642T1 (de) 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln
ATE96024T1 (de) Thiosulfinsaeurederivate, und die verwendung von thiosulfinsaeurederivaten zur herstellung von arzneimitteln fuer die behandlung von entzuendungserkrankungen.
ATE101846T1 (de) Verfahren zur herstellung von 1,1dichlorotetrafluorethan.
DE3784768T2 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
DE59007022D1 (de) Verfahren zur kontinuierlichen Herstellung von Nylon 4,6.
ATE139696T1 (de) Verwendung von benzothiazepinen zur herstellung von arzneimitteln zur behandlung von epileptischen anfällen
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
DE3679780D1 (de) Substituierte aminosulfonyl-6-nitrobenzosaeureester oder -amide, verfahren zur herstellung und diese enthaltende heilmittel.
IT8721354A0 (it) Procedimento per la realizzazione di dadi filettati, nonche' prodotto semilavorato per la produzione di dadi filettati.
ATE97678T1 (de) Verfahren zur herstellung von copolyarylensulfiden.
ATE100838T1 (de) Verfahren zur herstellung von copolyarylensulfiden.
ATE62895T1 (de) Verfahren zur herstellung von kohlenstoffmolekularsieben.
DE500713T1 (de) Derivate des 3,3,5-trimethylcyclohexylesters von 2-methylpropionsaeure, ihr herstellungsverfahren sowie diese enthaltende therapeutische kompositionen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SERONO PHARMA S.P.A., ROM/ROMA, IT

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8327 Change in the person/name/address of the patent owner

Owner name: INDUSTRIA FARMACEUTICA SERONO S.P.A., ROM/ROMA, IT